Skip to content

KZIA

Kazia Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$10.39
−4.33%
Ask drillr

Next report

Analyst consensus

Next report date
Mar 2, 2027
EPS estimate
-$0.45
Revenue estimate

Latest reported

Last report date
Sep 4, 2026
EPS actual
-$0.60
EPS estimate
-$0.61
Revenue actual
$183.4K
Revenue estimate
$488.9K

Track record

Trailing twelve quarters

EPS beats (12Q)
5
EPS misses (12Q)
0
EPS in line (12Q)
1
Avg surprise (4Q)
+74.8%
Revenue beats (12Q)
1

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$35
PT range
$29 – $40
Analysts
2
2 Buy0 Hold0 Sell
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Sep 4, 2026-$0.61-$0.60Beat 0.88%$183.4K
Nov 19, 2024-$15-$0.04Beat 99.72%$1.7M
Nov 27, 2023-$1.66-$0.02Beat 98.79%$369
Mar 9, 2023-$25-$0.06Beat 99.74%
Oct 6, 2022-$30-$0.06Beat 99.80%-$2.0M
Jan 6, 2022-$0.07$7.2K
Sep 30, 2021-$2.30-$0.01Beat 99.49%$11.4M
Oct 22, 2020-$0.05$251.1K
Dec 31, 2019-$0.06$440.1K
Oct 24, 2018-$0.09$1.1M
Dec 31, 2017$0.01$1.1M
Aug 30, 2017-$0.10$3.2M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 2, 2027